Labs / Assays & in vitro testing

Entera
Jerusalem, Israel · enterabio.com
GLP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Entera is a clinical-stage biopharmaceutical company focused on oral peptide therapeutics. It develops tablet-format peptide and protein replacement therapies for conditions including osteoporosis, hypoparathyroidism, obesity, metabolic diseases, and short bowel syndrome. The company is based in Jerusalem, Israel.
They take quote requests by email.
What they offer
Oral peptide therapeutic development
Develops tablet-format peptide therapies using its N-Tab® platform to stabilize peptides in the gastrointestinal tract and promote absorption into the bloodstream.
Oral protein replacement therapy development
Creates once-daily oral tablet therapies intended to replace peptide or protein treatments for unmet medical needs.
N-Tab® platform development
Provides a proprietary platform designed to improve oral delivery of large hydrophilic peptides through proteolysis inhibition and permeability enhancement.
What they work on
- Modalities
- Small molecule, Antibody, Bispecific, Peptide
- Species and models
- large animals
- Therapeutic areas
- osteoporosis, hypoparathyroidism, obesity, metabolic diseases, short bowel syndrome
- Sites
- Jerusalem, Israel
- Serves
- global
- Founded
- 2018
Public records
- Ownership
- ENTERA S.R.L. · IT GLEIF
Similar labs. Aurigene Pharmaceutical Services, Bioneeds, EyeCRO, Liveon Biolabs
Found in a contract services directory. Listing built from enterabio.com. Work here? Claim this listing.